Mydecine Innovations Group Stock Alpha and Beta Analysis

MYCOF Stock  USD 0.01  0  28.57%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Mydecine Innovations Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in Mydecine Innovations over a specified time horizon. Remember, high Mydecine Innovations' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Mydecine Innovations' market risk premium analysis include:
Beta
6.26
Alpha
6.67
Risk
42.88
Sharpe Ratio
0.15
Expected Return
6.64
Please note that although Mydecine Innovations alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Mydecine Innovations did 6.67  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Mydecine Innovations Group stock's relative risk over its benchmark. Mydecine Innovations has a beta of 6.26  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mydecine Innovations will likely underperform. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Mydecine Innovations Backtesting, Mydecine Innovations Valuation, Mydecine Innovations Correlation, Mydecine Innovations Hype Analysis, Mydecine Innovations Volatility, Mydecine Innovations History and analyze Mydecine Innovations Performance.

Mydecine Innovations Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Mydecine Innovations market risk premium is the additional return an investor will receive from holding Mydecine Innovations long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Mydecine Innovations. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Mydecine Innovations' performance over market.
α6.67   β6.26

Mydecine Innovations expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Mydecine Innovations' Buy-and-hold return. Our buy-and-hold chart shows how Mydecine Innovations performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Mydecine Innovations Market Price Analysis

Market price analysis indicators help investors to evaluate how Mydecine Innovations pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mydecine Innovations shares will generate the highest return on investment. By understating and applying Mydecine Innovations pink sheet market price indicators, traders can identify Mydecine Innovations position entry and exit signals to maximize returns.

Mydecine Innovations Return and Market Media

The median price of Mydecine Innovations for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 is 0.006 with a coefficient of variation of 36.61. The daily time series for the period is distributed with a sample standard deviation of 0.0, arithmetic mean of 0.01, and mean deviation of 0.0. The Stock did not receive any noticable media coverage during the period.
 Price Growth (%)  
       Timeline  

About Mydecine Innovations Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Mydecine or other pink sheets. Alpha measures the amount that position in Mydecine Innovations has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mydecine Innovations in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mydecine Innovations' short interest history, or implied volatility extrapolated from Mydecine Innovations options trading.

Build Portfolio with Mydecine Innovations

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Other Information on Investing in Mydecine Pink Sheet

Mydecine Innovations financial ratios help investors to determine whether Mydecine Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mydecine with respect to the benefits of owning Mydecine Innovations security.